Youngevity International, Inc. (NASDAQ: YGYI), announced that it received a letter from the Listing Qualifications Department of The Nasdaq Stock Market. The letter indicated that, as a result of Youngevity’s delay in filing its Annual Report on Form 10-K for the fiscal year ended December 31, 2019, Youngevity is not in compliance with the timely filing requirement for…

Read More
Acquisition of BeneYOU

Youngevity International, Inc. recently provided an update on the impact of the COVID-19 virus on its operations. All three reporting segments of the company have been able to continue operations as each segment falls in the category of an essential business. Although, relative to other businesses effected by COVID-19, the company is able and continues to generate…

Read More
Youngevity Acquires of Khrysos Global

Youngevity® International, Inc. announced the company is exploring the divestiture of its direct selling business unit back to the original founders of the direct selling division. The company, a leading multi-channel lifestyle company operating in three distinct business segments including a commercial coffee enterprise and a commercial hemp enterprise, has entered into a non-binding term sheet regarding…

Read More
Youngevity Acquires of Khrysos Global

Youngevity International, Inc. announced changes to its Board of Directors. The company stated that effective February 11, 2020, in order to maintain compliance with the corporate governance requirements of The Nasdaq Capital Market, and specifically Listing Rule 5605(b) which provides that a listed company’s board of directors shall be comprised of a majority of independent directors, Michelle…

Read More

Youngevity® International, Inc. announced it will ring in the new year on January 7, 2020, at the Nasdaq Stock Market Closing Bell ceremony in Times Square. In celebration of Nasdaq’s ninth annual “Fit Week,” Youngevity’s executive leadership will gather alongside company distributors as well as members of the Youngevity team and Celebrity Brand Ambassadors Marilu Henner and Dr. James Rouse to ring the closing…

Read More
Youngevity Q3 2019

Youngevity International, Inc. reported revenue of $34 million for the three months ended September 30, 2019, down 13 percent from Q3 2018. Direct selling revenue down nearly 12% for the quarter “Although we have recently made great strides in producing revenue growth this year, the third quarter posed a number of challenges as we faced seasonally slower sales for…

Read More
Acquisition of BeneYOU

Youngevity International, Inc. announced that is has closed the acquisition of BeneYOU, LLC’s assets with an effective date of November 1, 2019. “We are proud to welcome the customers and distributors of Jamberry, Avisae and M.Global into our organization and we look forward to showcasing all of their exciting products to Youngevity distributors and customers…

Read More
BeneYOU

Youngevity International, Inc., and BeneYOU LLC  announced they have executed a non-binding Letter of Intent whereby Youngevity will purchase certain assets of BeneYOU. Both Youngevity, a leading multi-channel lifestyle company, and BeneYOU, a nutritional and beauty products company, have acknowledged their plans to execute a definitive Asset Purchase Agreement in the coming weeks with an…

Read More
Khrysos

Khrysos Industries, Inc. a wholly owned subsidiary of Youngevity International (YGYI), recently announced a five-year supply contract with Magu Maiden Farms, LLC. The contract is to provide extraction services and end-to-end processing to produce isolate, water soluble isolate, distillate and water-soluble distillate hemp derived products. “We are excited to add this new long-term contract to our…

Read More
Youngevity Q3 2019

Youngevity International, Inc. (NASDAQ: YGYI)  announced it is set to join the broad-market Russell 3000® Index at the conclusion of the 2019 Russell indexes annual reconstitution. Annual Russell indexes reconstitution captures the 4,000 largest US stocks as of May 10, ranking them by total market capitalization. Membership in the U.S. all-cap Russell 3000® Index, which…

Read More